Benatti Luca bought QNCX
October 23, 2024 · Form 4 insider transaction
Benatti Luca bought 8,918 shares of Quince Therapeutics, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 432 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,918
Price
N/A
Total value
N/A
InsiderBenatti Luca
RoleDirector
SecurityCommon Stock
Transaction codeJ: J
Transaction dateOctober 23, 2024
Filing dateDecember 29, 2025
Shares owned after89,179
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
In connection with the Stock Purchase Agreement between the Issuer and EryDel Italy Inc.announced in the Issuer's 8-k filed with the Securities and Exchange Commission on July 24, 2023 (the "Acquisition"), 10% of the shares of common stock of the Issuer issued to the Reporting Person in connection with the Acquisition were held back for one (1) year following closing and released to the Reporting Person on October 23, 2024.